Latest Insider Transactions at Eli Lilly & CO (LLY)
This section provides a real-time view of insider transactions for Eli Lilly & CO (LLY). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of ELI LILLY & Co to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of ELI LILLY & Co's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 18
2022
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
40
+0.06%
|
$9,880
$247.07 P/Share
|
|
Dec 30
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
3,614
-0.0%
|
$1,008,306
$279.55 P/Share
|
|
Dec 27
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
3,570
-0.0%
|
$996,030
$279.53 P/Share
|
|
Dec 20
2021
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
41
+0.08%
|
-
|
|
Dec 20
2021
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
37
+3.39%
|
$9,731
$263.48 P/Share
|
|
Dec 20
2021
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.01%
|
$2,104
$263.48 P/Share
|
|
Dec 16
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
177,616
-0.04%
|
$49,910,096
$281.39 P/Share
|
|
Dec 15
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
205,000
-0.02%
|
$55,555,000
$271.49 P/Share
|
|
Nov 15
2021
|
Gabrielle Sulzberger Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+50.0%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
685
+0.55%
|
$176,730
$258.43 P/Share
|
|
Nov 15
2021
|
Marschall S Runge Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+4.27%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
J Erik Fyrwald Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+0.98%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
719
+0.7%
|
$185,502
$258.43 P/Share
|
|
Nov 15
2021
|
Juan R Luciano Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+4.8%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
Katherine Baicker Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+3.08%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
Karen Walker Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+12.03%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
William G Kaelin Jr Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+3.32%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
Jamere Jackson Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+8.02%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
Michael L Eskew Director |
BUY
Grant, award, or other acquisition
|
Direct |
677
+1.48%
|
$174,666
$258.43 P/Share
|
|
Nov 15
2021
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
658
+23.29%
|
$169,764
$258.43 P/Share
|
|
Nov 04
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
195,000
-0.03%
|
$52,260,000
$268.86 P/Share
|
|
Oct 28
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
178,631
-0.03%
|
$45,372,274
$254.46 P/Share
|
|
Oct 27
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
21,369
-0.02%
|
$5,384,988
$252.33 P/Share
|
|
Oct 18
2021
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.01%
|
$1,904
$238.98 P/Share
|
|
Oct 18
2021
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
40
+10.15%
|
$9,520
$238.98 P/Share
|
|
Oct 18
2021
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
46
+0.09%
|
$10,948
$238.98 P/Share
|
|
Sep 20
2021
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
9
+0.01%
|
$2,079
$231.64 P/Share
|
|
Sep 20
2021
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
42
+11.8%
|
-
|
|
Sep 20
2021
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.09%
|
$10,857
$231.64 P/Share
|
|
Aug 18
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
15,430
-0.01%
|
$4,227,820
$274.31 P/Share
|
|
Aug 17
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
3,060
-0.0%
|
$838,440
$274.08 P/Share
|
|
Aug 16
2021
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
7
+0.01%
|
$1,883
$269.94 P/Share
|
|
Aug 16
2021
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
36
+11.73%
|
$9,684
$269.94 P/Share
|
|
Aug 16
2021
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
40
+0.08%
|
$10,760
$269.94 P/Share
|
|
Aug 09
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
104,711
-0.01%
|
$28,062,548
$268.61 P/Share
|
|
Aug 06
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
7,597
-0.01%
|
$2,005,608
$264.05 P/Share
|
|
Aug 05
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
132,692
-0.06%
|
$35,030,688
$264.73 P/Share
|
|
Aug 04
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
13,458
-0.0%
|
$3,566,370
$265.09 P/Share
|
|
Aug 03
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
236,542
-0.07%
|
$60,791,294
$257.26 P/Share
|
|
Jul 21
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
86,111
-0.08%
|
$20,408,307
$237.0 P/Share
|
|
Jul 20
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
15,610
-0.01%
|
$3,699,570
$237.06 P/Share
|
|
Jul 19
2021
|
Kimberly H Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
41
+14.86%
|
$9,594
$234.14 P/Share
|
|
Jul 19
2021
|
Jackson P Tai Director |
BUY
Grant, award, or other acquisition
|
Direct |
8
+0.01%
|
$1,872
$234.14 P/Share
|
|
Jul 19
2021
|
Ralph Alvarez Director |
BUY
Grant, award, or other acquisition
|
Direct |
47
+0.09%
|
$10,998
$234.14 P/Share
|
|
Jul 14
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
10,780
-0.01%
|
$2,554,860
$237.02 P/Share
|
|
Jul 12
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
3,238
-0.0%
|
$767,406
$237.09 P/Share
|
|
Jul 09
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
109,261
-0.05%
|
$25,894,857
$237.69 P/Share
|
|
Jul 06
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
210,000
-0.19%
|
$49,350,000
$235.09 P/Share
|
|
Jul 02
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
202,102
-0.06%
|
$47,089,766
$233.46 P/Share
|
|
Jun 24
2021
|
Lilly Endowment Inc |
SELL
Open market or private sale
|
Direct |
12,898
-0.01%
|
$3,056,826
$237.79 P/Share
|